Another telemedicine company has jumped on the cheap, no-name weight-loss product bandwagon. AI stocks’ triumph will continue, says strategist Lemonaid Health, a subsidiary of 23andMe, announced on Wednesday that it…
GLP-1 therapies just got significantly more affordable for patients paying out-of-pocket. Eli Lilly’s single-dose vials of Zepbound (tirzepatide) are now available at similar prices to compounded versions of semaglutide. Patients…
Eli Lilly has reduced the cost of lower doses of its popular weight-loss drug Zepbound – but only for patients who pay for the drug out of pocket. The drug…
Until now, Zepbound has been packaged in a single device, an injection pen that contains both the medication and the needle. Patients press a button on one end to insert…
INDIANAPOLIS (AP) — Eli Lilly beat expectations for the second quarter, with diabetes drug Mounjaro and its weight-loss counterpart Zepbound bringing the drugmaker sales of more than $4 billion. In…
Demand for popular prescription drugs used to treat diabetes, obesity and heart disease has skyrocketed in recent years. New research from the University of Southern California showed a 442% increase…
